Cost-Effectiveness Analysis of Bendamustine-Rituximab Treatment Compared with Fludarabine-Rituximab Treatment, in Patients with Indolent Non-Hodgkin’s Lymphoma in Costa Rica

Autor:	Desanvicente-Celis, Z., Obando, C.A., Chaves, M., Gonzalez, L., Muschett, D.
Rok vydání:	2014
Předmět:	hemic and lymphatic diseases Health Policy Public Health Environmental and Occupational Health health care economics and organizations
Zdroj:	Value in Health. 17:A85
ISSN:	1098-3015
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76969b076c8de0f7ca6622ddc1d669ee https://doi.org/10.1016/j.jval.2014.03.497 Zobrazit plný text záznamu Full Text from ScienceDirect